DDDuPont
Is the price fair?
A demanding price: priced for +17% a year vs −18% a year delivered and well above its own median P/E.
Priced for ~17% a year FCF growth. The price already bakes in strong, sustained growth.
Expensive vs its own history: P/E 17.5 vs a 7.9 median over 19 quarters (+121% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What DD's price assumes
DuPont trades at 289× earnings against 29.4× for the median Specialty Chemicals name, more expensive than its own group.
Trailing P/E · Specialty Chemicals median 29.4 · 9.82× the median: the market pays up for this one
- Price / sales
- 2.77
Price / sales · today's price, trailing year to Jun 30, 2026
- Free cash flow yield
- 2.1%
Free cash flow yield · Specialty Chemicals median 4.7%
- Growth the price implies
- +17%
Growth the price implies · The price pays for +17% free cash flow growth a year for a decade; revenue has grown −18% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 1.40
- EV / salestoday's price, trailing year to Jun 30, 2026
- 2.96
- Basic Materials median P/E203 names
- 20.7
- Specialty Chemicals median P/E43 names
- 29.4
- Free cash flow, trailing twelve months
- $402M
- Market capitalisation
- $19.3B
- 3-year revenue growth
- −18%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 17.5× today against a 7.92× median |
| 52-week range | $88.94 – $151.66 |
| Today | $130.03 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
The closest names by size in the same industry